
Accentus Medical is pleased to announce the advancement in clinical adoption of its proprietary Acusure Ag® coating on a groundbreaking orthopaedic device enabling external surgical implants to be directly attached into bone.
Update your browser to view this website correctly. Update my browser now
Accentus Medical is pleased to announce the advancement in clinical adoption of its proprietary Acusure Ag® coating on a groundbreaking orthopaedic device enabling external surgical implants to be directly attached into bone.
Accentus Medical is implementing a business continuity plan and remains well prepared to continue to work effectively during the COVID19 pandemic, to assist and support our global customer base during this forthcoming difficult time.iew text as example
Accentus Medical is pleased to announce a funding award from Innovate UK. The project is driven by recent market trend towards more complex device materials, such as 3-D porous structures formed by additive layer manufacturing techniques.
Accentus Medical, a leading developer of advanced surface modifications and coating technologies, is delighted to announce its success in winning the Best New UK Medtech Development Programme in the OBN 2015 Awards.
Accentus Medical is pleased to announce a funding award from Innovate UK towards a project targeted at demonstrating production line readiness of its innovative Acusure Ag® silver ion based antimicrobial hydroxyapatite coating for orthopaedic implants.